Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics

Molecular and Cellular Proteomics

Volumn 12, Issue 8, 2013, Pages 2070-2080

  Gnad, Florian ^a   Young, Amy ^a   Zhou, Wei ^a   Lyle, Karen ^a   Ong, Christy C ^a   Stokes, Matthew P ^b   Silva, Jeffrey C ^b   Belvin, Marcia ^a   Friedman, Lori S ^a   Koeppen, Hartmut ^b   Minden, Audrey ^c   Hoeflich, Klaus P ^a  

^a GENENTECH INC   (United States)

^b CELL SIGNALING TECHNOLOGY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; P21 ACTIVATED KINASE 4; PROTEIN CDC42; CDC42 PROTEIN, MOUSE; KRAS2 PROTEIN, MOUSE; P21 ACTIVATED KINASE; PAK4 PROTEIN, MOUSE; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; PROTEIN P21;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOSKELETON; DEPOLYMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS; 3T3 CELL LINE; ANIMAL; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION;

ANIMALS; CDC42 GTP-BINDING PROTEIN; MICE; NIH 3T3 CELLS; P21-ACTIVATED KINASES; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOMICS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 84881101018     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.027052     Document Type: Article

References (63)

1. Schubbert, S., Shannon, K., and Bollag, G. (2007) Hyperactive Ras in developmental disorders and cancer. Nat. Rev. 7, 295-308
2. Baines, A. T., Xu, D., and Der, C. J. (2011) Inhibition of Ras for cancer treatment: the search continues. Future Med. Chem. 3, 1787-1808
3. Gysin, S., Salt, M., Young, A., and McCormick, F. (2011) Therapeutic strategies for targeting ras proteins. Genes Cancer 2, 359-372
4. Courtney, K. D., Corcoran, R. B., and Engelman, J. A. (2010) The PI3K pathway as drug target in human cancer. J. Clin. Oncol. 28, 1075-1083
5. Pratilas, C. A., and Solit, D. B. (2010) Targeting the mitogen-Activated protein kinase pathway: physiological feedback and drug response. Clin. Cancer Res. 16, 3329-3334
6. Bai, Y., Edamatsu, H., Maeda, S., Saito, H., Suzuki, N., Satoh, T., and Kataoka, T. (2004) Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res. 64, 8808-8810
7. Gonzalez-Garcia, A., Pritchard, C. A., Paterson, H. F., Mavria, G., Stamp, G., and Marshall, C. J. (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7, 219-226
8. Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., and Der, C. J. (1995) Activation of Rac1, RhoA, and mitogen-Activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15, 6443-6453
9. Malliri, A., van der Kammen, R. A., Clark, K., van der Valk, M., Michiels, F., and Collard, J. G. (2002) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417, 867-871
10. Qiu, R. G., Chen, J., Kirn, D., McCormick, F., and Symons, M. (1995) An essential role for Rac in Ras transformation. Nature 374, 457-459
11. White, M. A., Nicolette, C., Minden, A., Polverino, A., Van Aelst, L., Karin, M., and Wigler, M. H. (1995) Multiple Ras functions can contribute to mammalian cell transformation. Cell 80, 533-541
12. Cheng, C. M., Li, H., Gasman, S., Huang, J., Schiff, R., and Chang, E. C. (2011) Compartmentalized Ras proteins transform NIH 3T3 cells with different efficiencies. Mol. Cell. Biol. 31, 983-997
13. Stengel, K. R., and Zheng, Y. (2012) Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting. PloS One 7, e37317
14. Zheng, Y., Xia, Y., Hawke, D., Halle, M., Tremblay, M. L., Gao, X., Zhou, X. Z., Aldape, K., Cobb, M. H., Xie, K., He, J., and Lu, Z. (2009) FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol. Cell 35, 11-25
15. Stengel, K., and Zheng, Y. (2011) Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell. Signal. 23, 1415-1423
16. Liu, Y., Wang, Y., Zhang, Y., Miao, Y., Zhao, Y., Zhang, P. X., Jiang, G. Y., Zhang, J. Y., Han, Y., Lin, X. Y., Yang, L. H., Li, Q. C., Zhao, C., and Wang, E. H. (2009) Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer 63, 375-382
17. Gómez Del Pulgar, T., Valdés-Mora, F., Bandres, E., Perez-Palacios, R., Espina, C., Cejas, P., Garcia-Cabezas, M. A., Nistal, M., Casado, E., Gonzalez-Baron, M., Garcia-Foncillas, J., and Lacal, J. C. (2008) Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int. J. Oncol. 33, 185-193
18. Tucci, M. G., Lucarini, G., Brancorsini, D., Zizzi, A., Pugnaloni, A., Giacchetti, A., Ricotti, G., and Biagini, G. (2007) Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br. J. Dermatol. 157, 1212-1216
19. Kamai, T., Yamanishi, T., Shirataki, H., Takagi, K., Asami, H., Ito, Y., and Yoshida, K. (2004) Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin. Cancer Res. 10, 4799-4805
20. Fritz, G., Just, I., and Kaina, B. (1999) Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81, 682-687
21. Appledorn, D. M., Dao, K. H., O'Reilly, S., Maher, V. M., and McCormick, J. J. (2010) Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts. BMC Cancer 10, 13
22. Qiu, R. G., Abo, A., McCormick, F., and Symons, M. (1997) Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell. Biol. 17, 3449-3458
23. Crawford, J. J., Hoeflich, K. P., and Rudolph, J. (2012) p21-Activated kinase inhibitors: a patent review. Expert Opin. Ther. Pat. 22, 293-310
24. Ong, C. C., Jubb, A. M., Zhou, W., Haverty, P. M., Harris, A. L., Belvin, M., Friedman, L. S., Koeppen, H., and Hoeflich, K. P. (2011) p21-Activated kinase 1: PAK'ed with potential. Oncotarget 2, 491-496
25. Kumar, R., Gururaj, A. E., and Barnes, C. J. (2006) p21-Activated kinases in cancer. Nat. Rev. Cancer 6, 459-471
26. Whale, A., Hashim, F. N., Fram, S., Jones, G. E., and Wells, C. M. (2011) Signalling to cancer cell invasion through PAK family kinases. Front. Biosci. 16, 849-864
27. Callow, M. G., Clairvoyant, F., Zhu, S., Schryver, B., Whyte, D. B., Bischoff, J. R., Jallal, B., and Smeal, T. (2002) Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J. Biol. Chem. 277, 550-558
28. Chen, S., Auletta, T., Dovirak, O., Hutter, C., Kuntz, K., El-ftesi, S., Kendall, J., Han, H., Von Hoff, D. D., Ashfaq, R., Maitra, A., Iacobuzio-Donahue, C. A., Hruban, R. H., and Lucito, R. (2008) Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification. Cancer Biol. Ther. 7, 1793-1802
29. Kimmelman, A. C., Hezel, A. F., Aguirre, A. J., Zheng, H., Paik, J. H., Ying, H., Chu, G. C., Zhang, J. X., Sahin, E., Yeo, G., Ponugoti, A., Nabioullin, R., Deroo, S., Yang, S., Wang, X., McGrath, J. P., Protopopova, M., Ivanova, E., Zhang, J., Feng, B., Tsao, M. S., Redston, M., Protopopov, A., Xiao, Y., Futreal, P. A., Hahn, W. C., Klimstra, D. S., Chin, L., and DePinho, R. A. (2008) Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 19372-19377
30. Parsons, D. W., Wang, T. L., Samuels, Y., Bardelli, A., Cummins, J. M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J. K., Markowitz, S., Kinzler, K. W., Vogelstein, B., Lengauer, C., and Velculescu, V. E. (2005) Colorectal cancer: mutations in a signalling pathway. Nature 436, 792
31. Paliouras, G. N., Naujokas, M. A., and Park, M. (2009) Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor. Mol. Cell. Biol. 29, 3018-3032
32. Liu, Y., Xiao, H., Tian, Y., Nekrasova, T., Hao, X., Lee, H. J., Suh, N., Yang, C. S., and Minden, A. (2008) The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol. Cancer Res. 6, 1215-1224
33. Dan, C., Kelly, A., Bernard, O., and Minden, A. (2001) Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J. Biol. Chem. 276, 32115-32121
34. Callow, M. G., Zozulya, S., Gishizky, M. L., Jallal, B., and Smeal, T. (2005) PAK4 mediates morphological changes through the regulation of GEF H1. J. Cell Sci. 118, 1861-1872
35. Cammarano, M. S., Nekrasova, T., Noel, B., and Minden, A. (2005) Pak4 induces premature senescence via a pathway requiring p16INK4/ p19ARF and mitogen-Activated protein kinase signaling. Mol. Cell. Biol. 25, 9532-9542
36. Gnesutta, N., Qu, J., and Minden, A. (2001) The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276, 14414-14419
37. Rennefahrt, U. E., Deacon, S. W., Parker, S. A., Devarajan, K., Beeser, A., Chernoff, J., Knapp, S., Turk, B. E., and Peterson, J. R. (2007) Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J. Biol. Chem. 282, 15667-15678
38. Guha, U., Chaerkady, R., Marimuthu, A., Patterson, A. S., Kashyap, M. K., Harsha, H. C., Sato, M., Bader, J. S., Lash, A. E., Minna, J. D., Pandey, A., and Varmus, H. E. (2008) Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc. Natl. Acad. Sci. U.S.A. 105, 14112-14117
39. Sudhir, P. R., Hsu, C. L., Wang, M. J., Wang, Y. T., Chen, Y. J., Sung, T. Y., Hsu, W. L., Yang, U. C., and Chen, J. Y. (2011) Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas. PLoS One 6, e20199
40. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., and Mann, M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648
41. Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., Gnad, F., Cox, J., Jensen, T. S., Nigg, E. A., Brunak, S., and Mann, M. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3, ra3
42. Pan, C., Gnad, F., Olsen, J. V., and Mann, M. (2008) Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors. Proteomics 8, 4534-4546
43. Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X. M., Polakiewicz, R. D., and Comb, M. J. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94-101
44. Gnad, F., de Godoy, L. M., Cox, J., Neuhauser, N., Ren, S., Olsen, J. V., and Mann, M. (2009) High-Accuracy identification and bioinformatic analysis of in vivo protein phosphorylation sites in yeast. Proteomics 9, 4642-4652
45. Zielinska, D. F., Gnad, F., Jedrusik-Bode, M., Wiśniewski, J. R., and Mann, M. (2009) Caenorhabditis elegans has a phosphoproteome atypical for metazoans that is enriched in developmental and sex determination proteins. J. Proteome Res. 8, 4039-4049
46. Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., and Gygi, S. P. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-1189
47. Amanchy, R., Zhong, J., Hong, R., Kim, J. H., Gucek, M., Cole, R. N., Molina, H., and Pandey, A. (2009) Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling. Mol. Oncol. 3, 439-450
48. Moritz, A., Li, Y., Guo, A., Villén, J., Wang, Y., MacNeill, J., Kornhauser, J., Sprott, K., Zhou, J., Possemato, A., Ren, J. M., Hornbeck, P., Cantley, L. C., Gygi, S. P., Rush, J., and Comb, M. J. (2010) Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 3, ra64
49. Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., Hu, Y., Tan, Z., Stokes, M., Sullivan, L., Mitchell, J., Wetzel, R., Macneill, J., Ren, J. M., Yuan, J., Bakalarski, C. E., Villen, J., Kornhauser, J. M., Smith, B., Li, D., Zhou, X., Gygi, S. P., Gu, T. L., Polakiewicz, R. D., Rush, J., and Comb, M. J. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190-1203
50. Stokes, M. P., Farnsworth, C. L., Moritz, A., Silva, J. C., Jia, X., Lee, K. A., Guo, A., Polakiewicz, R. D., and Comb, M. J. (2012) PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS. Mol. Cell. Proteomics 11, 187-201
51. Stokes, M. P., Silva, J. C., Jia, X., Lee, K. A., Polakiewicz, R. D., and Comb, M. J. (2012) Quantitative Profiling of DNA Damage and Apoptotic Pathways in UV Damaged Cells Using PTMScan Direct. Int. J. Mol. Sci. 14, 286-307
52. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S., and Mann, M. (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4, 2010-2021
53. Lundgren, D. H., Martinez, H., Wright, M. E., and Han, D. K. (2009) Protein identification using Sorcerer 2 and SEQUEST. Curr. Protoc. Bioinformatics Chapter 13, Unit 13 13
54. Zhang, H., Zha, X., Tan, Y., Hornbeck, P. V., Mastrangelo, A. J., Alessi, D. R., Polakiewicz, R. D., and Comb, M. J. (2002) Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 277, 39379-39387
55. Prior, I. A., Lewis, P. D., and Mattos, C. (2012) A comprehensive survey of Ras mutations in cancer. Cancer Res. 72, 2457-2467
56. Cau, J., and Hall, A. (2005) Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways. J. Cell Sci. 118, 2579-2587
57. Jaffe, A. B., and Hall, A. (2005) Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269
58. Bompard, G., Rabeharivelo, G., Cau, J., Abrieu, A., Delsert, C., and Morin, N. (2012) P21-Activated kinase 4 (PAK4) is required for metaphase spindle positioning and anchoring. Oncogene. 32, 910-919
59. Tabusa, H., Brooks, T., and Massey, A. J. (2012) Knockdown of PAK4 or PAK1 Inhibits the Proliferation of Mutant KRAS Colon Cancer Cells Independently of RAF/MEK/ERK and PI3K/AKT Signaling. Mol. Cancer Res. 11, 109-121
60. Zhou, A. X., Hartwig, J. H., and Akyürek, L. M. (2010) Filamins in cell signaling, transcription and organ development. Trends Cell. Biol. 20, 113-123
61. Vadlamudi, R.K., Li, F., Adam, L., Nguyen, D., Ohta, Y., Stossel, T. P., and Kumar, R. (2002) Filamin is essential in actin cytoskeletal assembly mediated by p21-Activated kinase. Nat Cell Biol. 4, 681-690
62. Al-Bassam, J., and Chang, F. (2011) Regulation of microtubule dynamics by TOG-domain proteins XMAP215/Dis1 and CLASP. Trends Cell Biol. 21, 604-614
63. Lansbergen, G., Grigoriev, I., Mimori-Kiyosue, Y., Ohtsuka, T., Higa, S., Kitajima, I., Demmers, J., Galjart, N., Houtsmuller, A. B., Grosveld, F., and Akhmanova, A. (2006) CLASPs attach microtubule plus ends to the cell cortex through a complex with LL5beta. Dev. Cell 11, 21-32